EPS for Novo Nordisk A/S (NVO) Expected At $0.66

April 17, 2018 - By Henry Gaston

Novo Nordisk A/S (NYSE:NVO) Logo

Analysts expect Novo Nordisk A/S (NYSE:NVO) to report $0.66 EPS on May, 2.They anticipate $0.08 EPS change or 13.79 % from last quarter’s $0.58 EPS. NVO’s profit would be $1.59 billion giving it 18.64 P/E if the $0.66 EPS is correct. After having $0.53 EPS previously, Novo Nordisk A/S’s analysts see 24.53 % EPS growth. The stock increased 0.21% or $0.105 during the last trading session, reaching $49.215. About 653,896 shares traded. Novo Nordisk A/S (NYSE:NVO) has risen 42.07% since April 17, 2017 and is uptrending. It has outperformed by 30.52% the S&P500.

Novo Nordisk A/S (NYSE:NVO) Ratings Coverage

Among 6 analysts covering Novo Nordisk A\/S Common Stock (NYSE:NVO), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Novo Nordisk A\/S Common Stock had 6 analyst reports since December 1, 2017 according to SRatingsIntel. The company was upgraded on Friday, December 29 by J.P. Morgan. The firm has “Buy” rating given on Wednesday, December 6 by Bank of America. The rating was upgraded by JP Morgan to “Neutral” on Friday, December 29. Goldman Sachs maintained the shares of NVO in report on Friday, January 19 with “Buy” rating. The rating was upgraded by Morgan Stanley to “Overweight” on Friday, December 1.

Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. The company has market cap of $118.85 billion. It operates in two divisions, Diabetes and Obesity Care, and Biopharmaceuticals. It has a 19.39 P/E ratio. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles.

Novo Nordisk A/S (NYSE:NVO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.